$VHC
VirnetX Holding Corp

2020 Q3 Form 10-Q Financial Statement

#000114036120024851 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $26.00K $4.000K $38.00K
YoY Change 550.0% -42.86% 137.5%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin 0.0%
Selling, General & Admin $4.270M $4.016M $3.604M
YoY Change 6.32% -0.17% -31.9%
% of Gross Profit
Research & Development $1.091M $964.0K $986.0K
YoY Change 13.17% 3.43% -16.86%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $5.361M $4.980M $4.590M
YoY Change 7.65% 0.5% -29.14%
Operating Profit -$5.335M -$4.976M -$4.552M
YoY Change 7.21% 0.57% -29.56%
Interest Expense $0.00 $0.00 $27.00K
YoY Change 125.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.318M -$4.956M -$4.525M
YoY Change 7.3% 0.45% -29.84%
Income Tax -$1.293M $0.00 -$395.0K
% Of Pretax Income
Net Earnings -$4.025M -$4.956M -$4.130M
YoY Change -18.79% 0.45% -35.97%
Net Earnings / Revenue -15480.77% -123900.0% -10868.42%
Basic Earnings Per Share -$0.06 -$0.07 -$0.06
Diluted Earnings Per Share -$0.06 -$0.07 -$0.06
COMMON SHARES
Basic Shares Outstanding 71.06M 68.94M 68.26M
Diluted Shares Outstanding 71.06M 68.94M 68.26M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $248.0M $5.193M $6.927M
YoY Change 4675.66% -56.73% 47.38%
Cash & Equivalents $225.9M $2.572M $4.155M
Short-Term Investments $22.10M $2.621M $2.772M
Other Short-Term Assets $400.0K $300.0K $500.0K
YoY Change 33.33% -62.5% -44.44%
Inventory
Prepaid Expenses
Receivables $0.00 $6.000K $8.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $248.4M $5.514M $7.389M
YoY Change 4404.9% -56.92% 31.95%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $5.000K $5.000K
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.10M $1.721M $1.832M
YoY Change 486.87% 1.24% 1.78%
Total Long-Term Assets $10.15M $1.726M $1.837M
YoY Change 487.78% 1.53% 2.06%
TOTAL ASSETS
Total Short-Term Assets $248.4M $5.514M $7.389M
Total Long-Term Assets $10.15M $1.726M $1.837M
Total Assets $258.5M $7.240M $9.226M
YoY Change 3471.06% -50.07% 24.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K $1.200M $400.0K
YoY Change -50.0% 200.0% -86.67%
Accrued Expenses $9.700M $300.0K $300.0K
YoY Change 3133.33% 0.0% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.79M $1.600M $849.0K
YoY Change 1636.69% 60.0% -76.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.000K
YoY Change
Total Long-Term Liabilities $4.000K $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.79M $1.600M $849.0K
Total Long-Term Liabilities $4.000K $0.00 $0.00
Total Liabilities $27.79M $1.600M $800.0K
YoY Change 1636.94% 33.33% -78.38%
SHAREHOLDERS EQUITY
Retained Earnings -$563.0K -$213.1M -$208.2M
YoY Change -99.74%
Common Stock $7.000K $7.000K $7.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $230.8M $5.640M $8.377M
YoY Change
Total Liabilities & Shareholders Equity $258.5M $7.240M $9.226M
YoY Change 3471.06% -50.07% 24.68%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.025M -$4.956M -$4.130M
YoY Change -18.79% 0.45% -35.97%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$24.80M -$2.900M -$4.200M
YoY Change 755.17% -53.97% -32.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$19.50M $200.0K $200.0K
YoY Change -9850.0% 100.0% -200.0%
Cash From Investing Activities -$19.50M $200.0K $200.0K
YoY Change -9850.0% 100.0% -200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.200M 2.800M
YoY Change -100.0% -91.18% -41.67%
NET CHANGE
Cash From Operating Activities -24.80M -2.900M -4.200M
Cash From Investing Activities -19.50M 200.0K 200.0K
Cash From Financing Activities 0.000 1.200M 2.800M
Net Change In Cash -44.30M -1.500M -1.200M
YoY Change 2853.33% -120.27% -25.0%
FREE CASH FLOW
Cash From Operating Activities -$24.80M -$2.900M -$4.200M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 vhc Accrued Licensing Costs
AccruedLicensingCosts
9438000
CY2019Q4 vhc Accrued Licensing Costs
AccruedLicensingCosts
0
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
299000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
287000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
193000
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17414000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27787000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1826000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44000
CY2020Q3 us-gaap Liabilities
Liabilities
27791000
CY2019Q4 us-gaap Liabilities
Liabilities
1870000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
7000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26000
vhc Licensing Costs
LicensingCosts
0
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4956000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
316916000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15087000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1293000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71059000
us-gaap Net Income Loss
NetIncomeLoss
-14694000
dei Entity Central Index Key
EntityCentralIndexKey
0001082324
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
VirnetX Holding Corp
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5318000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5628000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4488000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
778000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
768000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1346000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
583000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Assets
Assets
7498000
CY2020Q3 us-gaap Assets
Assets
258545000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
302620000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50000
CY2020Q3 vhc Licensing Costs
LicensingCosts
0
CY2019Q3 vhc Licensing Costs
LicensingCosts
0
vhc Licensing Costs
LicensingCosts
90101000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1091000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
964000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6799000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2886000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4270000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4016000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38347000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12326000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5361000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
4980000
us-gaap Operating Expenses
OperatingExpenses
135247000
us-gaap Operating Expenses
OperatingExpenses
15212000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5335000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4976000
us-gaap Operating Income Loss
OperatingIncomeLoss
167373000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15162000
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2019Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
41271000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
17000
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
20000
us-gaap Interest And Other Income
InterestAndOtherIncome
108272000
us-gaap Interest And Other Income
InterestAndOtherIncome
75000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7498000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71058570
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71058570
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69586764
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69586764
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
231322000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
223237000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-217602000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
230754000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5628000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
258545000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
us-gaap Depreciation
Depreciation
4000
us-gaap Depreciation
Depreciation
4000
vhc Amortization Of Warrant Issued For Service
AmortizationOfWarrantIssuedForService
43000
us-gaap Net Income Loss
NetIncomeLoss
287880000
vhc Amortization Of Warrant Issued For Service
AmortizationOfWarrantIssuedForService
0
us-gaap Net Income Loss
NetIncomeLoss
-14694000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-4956000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29036000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-393000
us-gaap Net Income Loss
NetIncomeLoss
287880000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4025000
us-gaap Net Income Loss
NetIncomeLoss
-14694000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71059000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68943000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70780000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68278000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68943000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71663000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68278000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4025000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-4956000
us-gaap Net Income Loss
NetIncomeLoss
287880000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4025000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4955000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
287882000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14692000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5039000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3135000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7611000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225911000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4488000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6916000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
22519000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
5319000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2838000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4503000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19681000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-816000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1046000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7685000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
222776000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
816000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65663000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-224000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-286000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-763000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
118000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
62000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
17414000
us-gaap Payments Of Dividends
PaymentsOfDividends
70841000
us-gaap Payments Of Dividends
PaymentsOfDividends
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
47000
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div> <div><br/></div> <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we must make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in our accounting estimates are reasonably likely to occur. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on experience and other assumptions that we believe are reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below.</div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Reclassifications</div> <div><br/></div> <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported operating expenses, operating income or net income for any of the periods presented.</div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Our cash and cash equivalents are primarily maintained at </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. During the nine months ended </span>September<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> 30, 2020, we had funds which were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</span></div>
vhc Concentration Risk Number Of Financial Institutions
ConcentrationRiskNumberOfFinancialInstitutions
2
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
103853000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
103855000
CY2020Q3 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
247986000
CY2020Q3 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
247988000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3450000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2019Q4 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
5526000
CY2019Q4 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
5529000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1293000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5318000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29036000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
316916000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.092
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-393000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
37585000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8754000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
299945000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
299948000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
311610000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
953000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
104000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-78000
CY2020Q2 us-gaap Dividends Cash
DividendsCash
70841000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8040000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8041000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
233707000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1072000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4025000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4025000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
230754000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.00
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
9888000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2848000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
785000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
816000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5608000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5607000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
8730000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2849000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
928000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4130000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4130000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
8377000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1219000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-4956000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4955000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5640000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2803000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2712000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8754000
vhc Increase Decrease In Accrued Licensing Costs
IncreaseDecreaseInAccruedLicensingCosts
9438000
vhc Increase Decrease In Accrued Licensing Costs
IncreaseDecreaseInAccruedLicensingCosts
0
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-180000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-396000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
308120000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11908000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20377000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
vhc Licensing Costs
LicensingCosts
90101000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3453000
us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2020-05-08
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2020-05-18
CY2020Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
1
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2020-05-26
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71059000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68943000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70780000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68278000
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
883000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71059000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68943000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71663000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68278000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2814179

Files In Submission

Name View Source Status
0001140361-20-024851-index-headers.html Edgar Link pending
0001140361-20-024851-index.html Edgar Link pending
0001140361-20-024851.txt Edgar Link pending
0001140361-20-024851-xbrl.zip Edgar Link pending
brhc10016205_10q.htm Edgar Link pending
brhc10016205_10q_htm.xml Edgar Link completed
brhc10016205_ex31-1.htm Edgar Link pending
brhc10016205_ex31-2.htm Edgar Link pending
brhc10016205_ex32-1.htm Edgar Link pending
brhc10016205_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image00001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vhc-20200930.xsd Edgar Link pending
vhc-20200930_cal.xml Edgar Link unprocessable
vhc-20200930_def.xml Edgar Link unprocessable
vhc-20200930_lab.xml Edgar Link unprocessable
vhc-20200930_pre.xml Edgar Link unprocessable